Video

Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons™

Dr Marijn Vlaming, Head of Biology, et al. Charles River & bit.bio
Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons™

Dr Marijn Vlaming

Head of Biology

Charles River Laboratories

Dr Marijn Vlaming, Head of Biology, et al. Charles River & bit.bio
Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons™

Dr Marijn Vlaming

Head of Biology

Charles River Laboratories

We spoke to Dr Marijn Vlaming, Dr Mariangela Iovino and Dr Shushant Jain from Charles River to discuss how ioGlutamatergic Neurons are accelerating drug discovery by providing human derived, physiologically relevant models for high throughput screening.

Learn about the benefits of ioGlutamatergic Neurons and how they are accelerating CNS drug discovery:

  • By providing standardisation and improving reproducibility for researchers involved in high throughput screening
  • Offering a human derived, physiologically relevant model to reliably test compounds
  • Reducing the time it takes to culture glutamatergic neurons from over 90 days to just 10-14 days

Find out more about our ioGlutamatergic Neurons download the brochure here.

bit.bio and Charles River have partnered for translational drug development. Learn how you can screen and profile at Charles River with bit.bio ioCells.

Dr Marijn Vlaming et al.

Charles River & bit.bio

2021

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell identity coding platform behind our cells
Join us Explore the latest roles at bit.bio